Genome-wide association studies have detected more than 30 inherited prostate cancer risk
variants. While clearly associated with risk, their relationship with clinical outcome …

Recent genome-wide association studies have been successful in identifying common
sequence variants associated with prostate cancer risk; however, their importance in …

Purpose: Fifteen independent genetic variants have been implicated in prostate cancer risk
by recent genome-wide association studies. However, their association with …

Background Two prostate cancer genome-wide scans in populations of European ancestry
identified several genetic variants that are strongly associated with prostate cancer risk. The …

Background: Genome-wide association studies have identified multiple genetic variants
associated with prostate cancer risk which explain a substantial proportion of familial relative …

BACKGROUND Currently used prognostic markers are limited in their ability to accurately
predict disease progression among patients with localized prostate cancer. We examined 23 …

Background: Genome-wide association studies have identified numerous single nucleotide
polymorphisms (SNP) associated with the risk of prostate cancer. Our objective was to …

Purpose: Two recent genome-wide association studies have highlighted several single
nucleotide polymorphisms (SNPs) purported to be associated with prostate cancer risk. We …

Abstract Background: Of the 200,000 US men annually diagnosed with prostate cancer,
approximately 20% to 30% will have clinically aggressive disease. Although factors such as …

Genome-wide association studies (GWAS) have identified 76 variants associated with
prostate cancer risk predominantly in populations of European ancestry. To identify …